Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-21
1995-10-17
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514413, 514420, 514448, 514567, 514570, A61K 31415, A61K 3140, A61K 3130, A61K 3119
Patent
active
054591570
ABSTRACT:
A pharmaceutical aqueous solution for ophthalmic use comprising a nonsteroidal anti-inflammatory drug, having a carboxylic group, a decongestant drug and a mixture of a polysorbate and a poloxamer.
REFERENCES:
patent: 4734222 (1988-03-01), Winterton et al.
patent: 4988728 (1991-01-01), Gerson et al.
patent: 4996209 (1991-02-01), Aoki
patent: 5077033 (1991-12-01), Viegas et al.
patent: 5110493 (1992-05-01), Cherng-Chyi et al.
American Pharmaceutical Association, Handbook of Pharmaceutical Excipients, 1986, pp. 225-227.
Seghizzi et al., Chemical Abstracts, 118(10):87642n, 1992.
Siebenbrodt et al., Chemical Abstracts, 117(18):178192m, 1992.
Lanier et al., Medline, 83150710(AN), 1983.
Von Denffer et al., Chemical Abstracts, 88(13)83342d, 1977.
Chemical Abstracts, vol. 115, No. 17, Oct. 20, 1991, Columbus, Ohio Abstract No. 174581; Sulewski, Michael E. et al, "Effect of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol" p. 71, col. 2.
Chemical Abstracts, vol. 115, No. 17, Oct. 20, 1991, Columbus, Ohio, Abstract No. 174582, McCannel, Colin et al, "Topical flurbiprofen pretreatment does not block apraclonidine's effect on aqueous flow in humans" p. 72; col. 1. & Arch. Ophthamol, vol. 109, #6 1991, Chicago, pp. 810-811.
Martindale, The Extra Pharmacopoeia--XXIX Ed., The Pharmaceutical Press, 1989, pp. 872-881 ("Corticosteroids").
Ilic J., et al, Klin, MBL. Augenheilk, 184, 494-498 (1984) English Abstract.
Araie M, et al., Jpn. J. Opthalmol., 27, 535-542 (1983).
Merck Index, XI Ed., Ther-15, Ther-22, 1989.
Bonadeo Daniele
Gazzaniga Annibale
Stroppolo Federico
Virgano' Luigi
Henley III Raymond
Jarvis William R. A.
Zambon Group S.p.A.
LandOfFree
Pharmaceutical composition for ophthalmic use comprising a nonst does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for ophthalmic use comprising a nonst, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for ophthalmic use comprising a nonst will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597623